Advancements in Anti-Inflammatory Therapeutics

This chapter delves into the pharmaceutical program surrounding Solricotug, an anti-TSLP antibody, and its clinical progress in treating COPD, asthma, and eosinophilic esophagitis. The episode highlights the serious implications of EOE and the team's dedication to improving treatment options for these challenging conditions.

Transcript

Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.